Enrichment Strategies for Systemic Sclerosis-Interstitial Lung Disease Trials

被引：2
|
作者：
Volkmann, Elizabeth R. [1 ]
机构：
[1] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷 / 09期
关键词：
DOUBLE-BLIND; CYCLOPHOSPHAMIDE; TOCILIZUMAB; PLACEBO; ADULTS;
D O I：
10.1164/rccm.202401-0246ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1067 / 1068
页数：2
相关论文
共 50 条
  • [1] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [2] Recent progress in systemic sclerosis-interstitial lung disease
    Castelino, Flavia V.
    Dellaripa, Paul F.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (06) : 570 - 575
  • [3] Molecular imaging for systemic sclerosis-interstitial lung disease
    Volkmann, Elizabeth R.
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E163 - E164
  • [4] Enrichment strategies for clinical trials targeting skin fibrosis and interstitial lung disease in systemic sclerosis
    Herrick, Ariane L.
    Denton, Christopher P.
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (06) : 349 - 355
  • [5] Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
    Hoffmann-Vold, Anna -Maria
    Brunborg, Cathrine
    Airo, Paolo
    Ananyeva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Valentini, Gabriele
    Kowal-Bielecka, Otylia
    Allanore, Yannick
    Distler, Oliver
    CHEST, 2023, 163 (03) : 586 - 598
  • [6] Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients
    Guzelant, Gul
    Melikoglu, Melike
    Musellim, Benan
    Yilmaz, Deniz Demir
    Fresko, Izzet
    Seyahi, Emire
    Hatemi, Gulen
    Ugurlu, Serdal
    Hamuryudan, Vedat
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease Another Arrow in the Quiver?
    Matson, Scott M.
    Griffith, Melissa
    Lee, Joyce S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (06) : 608 - 610
  • [8] TO ASSESS DIFFERENT PROGNOSIS INTERVALS FOR PATIENTS WITH SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE
    Ovsynnikova, Olga
    Koneva, Olga
    Garzanova, Liudmila
    Ananyeva, Lidia
    Starovoytova, Mayya
    Desinova, Oxana
    CHEST, 2021, 160 (04) : 1264A - 1264A
  • [9] COHORT ENRICHMENT STRATEGIES FOR PROGRESSIVE INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS FROM EUSTAR
    Hoffmann-Vold, A. M.
    Brunborg, C.
    Airo, P.
    Ananyeva, L. P.
    Czirjak, L.
    Guiducci, S.
    Hachulla, E.
    Li, M.
    Mihai, C.
    Riemekasten, G.
    Sfikakis, P.
    Valentini, G.
    Kowal-Bielecka, O.
    Allanore, Y.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 103 - 104
  • [10] Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis from EUSTAR
    Hoffmann-Vold, Anna-Maria
    Brunborg, Cathrine
    Airo, Paolo
    Ananyeva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Valentini, Gabriele
    Kowal-Bielecka, Otylia
    Allanore, Yannick
    Distler, Oliver
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1050 - 1052
12345